参考文献/References:
[1] 张亚茹. ABO 基因启动子区 CpG 岛甲基化与多囊卵巢综合征的相关性研究[D]. 郑州: 郑州大学: 2018.
[2] 金芬品. AMHRⅡ,INSR基因DNA甲基化与PCOS表观遗传学研究[D]. 广州: 暨南大学,2015.
[3] 朱琳. Apelin与IL-18在多囊卵巢综合征患者血清中的表达及意义[D]. 新乡: 新乡医学院,2015.
[4] Helfer G, Wu Q F. Chemerin a multifaceted adipokine involved in metabolic disorders[J]. Journal of Endocrinology, 2018, 238(2): 79-94.
[5] Dimitriadis G K, Kaur J, Adya R, et al. Chemerin induces endothe-lial cell inflammation activation of nuclear factor -kappa beta and monocyte-endothelial adhesion[J]. Oncotarget, 2018, 9(24): 16678-16690.
[6] 蔡留芸,胡建国,龚阳阳, 等. Chemerin对卵巢颗粒细胞的影响及对PCOS发病机制的研究[J]. 重庆医科大学学报,2019,44(8): 1010-1015.
[7] 艾风连. RAB5B基因在中国汉族多囊卵巢综合征中易感性的验证及其与糖耐量关系的研究[D]. 合肥: 安徽医科大学,2016.
[8] 蒋艳珍,董建立. 多囊卵巢综合征患者性激素水平与胰岛素抵抗的相关性研究[J]. 中国实验诊断学,2000(3): 415-417.
[9] 王丙娟. 多囊卵巢综合征患者血清瘦素水平与相关因素分析[J]. 卫生职业教育,2015(1): 153-154.
[10] 张攀. 体成分,脂肪细胞因子与多囊卵巢综合征相关性研究[D]. 石家庄: 河北医科大学,2019.
[11] Zhang B, Shen S, Gu T, et al. Increased circulating conjugated primary bile acids are associated with hyperandrogenism in women with polycystic ovary syndrome[J]. The Journal of Steroid Biochemistry and Molecular Biology, 2019, 189: 171-175.
[12] Li M, Zhao H, Zhao S G, et al. The HMGA2-IMP2 pathway promotes granulosa cell proliferation in polycystic ovary syndrome[J]. The Journal of Clinical Endocrinology and Metabolism, 2019, 104(4): 1049-1059.
[13] González F, Considine R V, Abdelhadi O A, et al. Saturated fat ingestion promotes lipopolysaccharide-mediated inflammation and insulin resistance in polycystic ovary syndrome[J]. The Journal of Clinical Endocrinology and Metabolism, 2019, 104(3): 934-946.
[14] Li Y, Zhao W, Wang H, et al. Silencing of LncRNA steroid receptor RNA activator attenuates polycystic ovary syndrome in mice[J]. Biochimie, 2019, 157: 48-56.
[15] Lin H, Xing W, Li Y, et al. Downregulation of serum long noncoding RNA GAS5 may contribute to insulin resistance in PCOS patients[J]. Gynecological Endocrinology, 2018, 34(9): 784-788.
[16] 康丽兰,李玉香,周红香. 辨证论治联合艾灸治疗肥胖型多囊卵巢综合征不孕43例[J]. 中国中医药现代远程教育,2015(5): 61-62.
[17] 黎源. 补肾疏肝化痰法治疗肥胖型多囊卵巢综合征性不孕症35例[J]. 河南中医,2015,35(4): 844-845.
[18] 刘亚绒,张峰. 苍附导痰汤加减方联合二甲双胍治疗肥胖型多囊卵巢综合征的效果分析[J]. 山西医药杂志,2019(22): 21.
[19] 张秋仔,李宇青,倪凯宾,等. 苍附导痰汤联合来曲唑治疗肥胖型多囊卵巢综合征不孕的效果观察[J]. 中外医学研究,2019,17(33): 18-20.
[20] 陈玉星. 苍附导痰汤联合炔雌醇环丙孕酮片治疗肥胖型多囊卵巢综合征[J]. 河南医学研究,2019(18): 70.
[21] Shi Y, Li L, Zhou J, et al. Efficacy of electroacupuncture in regulating the imbalance of AMH and FSH to improve follicle development and hyperandrogenism in PCOS rats[J]. Biomedicine and Pharmacotherapy, 2019, 113: 108687.
[22] Zhang Y, Cao S, Wen S D, et al. Effect of acupuncture on reproductive endocrine and p-Akt protein expression in polycystic ovary syndrome rats with insulin resistance[J]. Acupuncture Research, 2018, 43(10): 622-626.
[23] Shi Y, Kong X, Yin H, et al. Effect of hawthorn leaf flavonoids in dehydroepiandrosterone-induced polycystic ovary syndrome in rats[J]. Pathobiology, 2019, 86(2-3): 102-110.
[24] Dou L, Zheng Y, Li L, et al. The effect of cinnamon on polycystic ovary syndrome in a mouse model[J]. Reproductive Biology and Endocrinology, 2018, 16(1): 99.
[25] Zhang N, Liu X, Zhuang L, et al. Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways[J]. Regulatory Toxicology and Pharmacology, 2020, 110: 104544.
[26] Stepto N K, Hiam D, Gibson-Helm M, et al. Exercise and insulin resistance in PCOS: muscle insulin signalling and fibrosis[J]. Endocrine Connections, 2020, 9(4): 346-359.
相似文献/References:
[1]李瑞祥 陈斯宁.中医药对 COPD 大鼠模型作用机理的研究进展[J].大众科技,2014,16(05):95.
[2]张 莉,张小蒙,周 敏.多年龄段痤疮的分层诊疗以及酒渣鼻关联性分析的研究进展[J].大众科技,2019,21(10):56.
Research Progress in the Treatment of Multistage Acne and Rosacea Correlation Analysis[J].Popular Science & Technology,2019,21(1):56.
[3]魏倍倍 林寒梅.脾虚痰湿型多囊卵巢综合征治疗现状研究[J].大众科技,2019,21(01):57.
Study on the Treatment of Spleen-deficiency and Phlegm-damp Type Polycystic Ovary Syndrome[J].Popular Science & Technology,2019,21(1):57.
[4]马玉珍,毛德文,陈月桥,等.轻微型肝性脑病发病机制的研究进展[J].大众科技,2019,21(04):72.
Research Progress on Pathogenesis of Minimal Hepatic Encephalopathy[J].Popular Science & Technology,2019,21(1):72.
[5]刘 英,吴媛媛,罗志娟.苍附导痰丸加减联合达英 35 治疗脾虚痰湿证多囊卵巢综合征的临床观察[J].大众科技,2019,21(04):78.
Clinical Observation of Modified Cang Fu Dao Tan Wan Combined with Diane-35in the Treatment of Polycystic Ovary Syndrome of Spleen-deficientPhlegm-dampness Syndrome[J].Popular Science & Technology,2019,21(1):78.
[6]刘 英,韦思尊,钟 洁.雷火灸联合仿生物电刺激对肥胖型多囊卵巢综合征患者代谢的影响[J].大众科技,2019,21(07):82.
Effect of Thunder Fire Moxibustion Combined with Biomimetic ElectricalStimulation on the Metabolism of Obese Polycystic Ovary Syndrome Patients[J].Popular Science & Technology,2019,21(1):82.
[7]吴铁雄 刘旭东 朱沪敏 黄 露 李品桦 庞华珍.非酒精性脂肪性肝病对肾功能指标影响的研究进展[J].大众科技,2021,23(6):63.
Research Progress on the Influence of Non-alcoholic Fatty Liver Disease on Renal Function Index[J].Popular Science & Technology,2021,23(1):63.
[8]黄凤积 张远景 农建平 莫彬杰 潘志良 董文兰.补肾化痰法联合达英-35治疗多囊卵巢综合症的Meta分析[J].大众科技,2021,23(11):53.
Meta Analysis of Kidney-Tonifying and Phlegm-Reducing Therapy Combined with Dayiny-35 in the Treatment of Polycystic Ovarian Syndrome[J].Popular Science & Technology,2021,23(1):53.
[9]韦柳婷 胡振斌 高松林 黄玲珊 韦湘红 张家增.中医药治疗非酒精性脂肪肝病的研究进展[J].大众科技,2023,25(3):85.
Research Progress of Traditional Chinese Medicine in the Treatment of Non-Alcoholic Fatty Liver Disease[J].Popular Science & Technology,2023,25(1):85.